Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Implementation Science
Published in: Implementation Science 1/2017

Open Access 01-12-2017 | Research

The effectiveness of a de-implementation strategy to reduce low-value blood management techniques in primary hip and knee arthroplasty: a pragmatic cluster-randomized controlled trial

Authors: Veronique M. A. Voorn, Perla J. Marang-van de Mheen, Anja van der Hout, Stefanie N. Hofstede, Cynthia So-Osman, M. Elske van den Akker-van Marle, Ad A. Kaptein, Theo Stijnen, Ankie W. M. M. Koopman-van Gemert, Albert Dahan, Thea P. M. M. Vliet Vlieland, Rob G. H. H. Nelissen, Leti van Bodegom-Vos

Published in: Implementation Science | Issue 1/2017

Login to get access

Abstract

Background

Perioperative autologous blood salvage and preoperative erythropoietin are not (cost) effective to reduce allogeneic transfusion in primary hip and knee arthroplasty, but are still used. This study aimed to evaluate the effectiveness of a theoretically informed multifaceted strategy to de-implement these low-value blood management techniques.

Methods

Twenty-one Dutch hospitals participated in this pragmatic cluster-randomized trial. At baseline, data were gathered for 924 patients from 10 intervention and 1040 patients from 11 control hospitals undergoing hip or knee arthroplasty. The intervention included a multifaceted de-implementation strategy which consisted of interactive education, feedback on blood management performance, and a comparison with benchmark hospitals, aimed at orthopedic surgeons and anesthesiologists. After the intervention, data were gathered for 997 patients from the intervention and 1096 patients from the control hospitals. The randomization outcome was revealed after the baseline measurement. Primary outcomes were use of blood salvage and erythropoietin. Secondary outcomes included postoperative hemoglobin, length of stay, allogeneic transfusions, and use of local infiltration analgesia (LIA) and tranexamic acid (TXA).

Results

The use of blood salvage (OR 0.08, 95% CI 0.02 to 0.30) and erythropoietin (OR 0.30, 95% CI 0.09 to 0.97) reduced significantly over time, but did not differ between intervention and control hospitals (blood salvage OR 1.74 95% CI 0.27 to 11.39, erythropoietin OR 1.33, 95% CI 0.26 to 6.84). Postoperative hemoglobin levels were significantly higher (β 0.21, 95% CI 0.08 to 0.34) and length of stay shorter (β −0.36, 95% CI −0.64 to −0.09) in hospitals receiving the multifaceted strategy, compared with control hospitals and after adjustment for baseline. Transfusions did not differ between the intervention and control hospitals (OR 1.06, 95% CI 0.63 to 1.78). Both LIA (OR 0.0, 95% CI 0.0 to 0.0) and TXA (OR 0.3, 95% CI 0.2 to 0.5) were significantly associated with the reduction in blood salvage over time.

Conclusions

Blood salvage and erythropoietin use reduced over time, but not differently between intervention and control hospitals. The reduction in blood salvage was associated with increased use of local infiltration analgesia and tranexamic acid, suggesting that de-implementation is assisted by the substitution of techniques. The reduction in blood salvage and erythropoietin did not lead to a deterioration in patient-related secondary outcomes.

Trial registration

www.trialregister.nl, NTR4044
Appendix
Available only for authorised users
Literature
1.
Levinson W, Kallewaard M, Bhatia RS, Wolfson D, Shortt S, Kerr EA. ‘Choosing Wisely’: a growing international campaign. BMJ Qual Saf. 2015;24:167–74.CrossRefPubMed
2.
Smith M, Saunders R, Stuckhardt L, McGinnis JM. Best Care at Lower Cost: The Path to Continuously Learning Health Care in America. National Academies Press (US). 2013. doi:10.​17226/​13444.
3.
Colla CH, Morden NE, Sequist TD, Schpero WL, Rosenthal MB. Choosing wisely: prevalence and correlates of low-value health care services in the United States. J Gen Intern Med. 2015;30:221–8.CrossRefPubMed
4.
van Bodegom-Vos L, Davidoff F, Marang-van de Mheen PJ. Implementation and de-implementation: two sides of the same coin? BMJ Qual Saf. 2016;26:495–501.
5.
6.
Grimshaw JM, Thomas RE, MacLennan G, Fraser C, Ramsay CR, Vale L et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess. 2004;8(6):iii–iv, 1–72.
7.
Grol R, Grimshaw J. From best evidence to best practice: effective implementation of change in patients’ care. Lancet. 2003;362:1225–30.CrossRefPubMed
8.
9.
Michie S, Johnston M, Abraham C, Lawton R, Parker D, Walker A. Making psychological theory useful for implementing evidence based practice: a consensus approach. Qual Saf Health Care. 2005;14:26–33.CrossRefPubMedPubMedCentral
10.
Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, et al. Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999;282:1458–65.CrossRefPubMed
11.
Baker R, Camosso-Stefinovic J, Gillies C, Shaw EJ, Cheater F, Flottorp S et al. Tailored interventions to overcome identified barriers to change: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2010;17(3):CD005470.
12.
Prior M, Guerin M, Grimmer-Somers K. The effectiveness of clinical guideline implementation strategies—a synthesis of systematic review findings. J Eval Clin Pract. 2008;14:888–97.CrossRefPubMed
13.
14.
Ubel PA, Asch DA. Creating value in health by understanding and overcoming resistance to de-innovation. Health Aff (Millwood). 2015;34:239–44.CrossRef
15.
Niven DJ, Mrklas KJ, Holodinsky JK, Straus SE, Hemmelgarn BR, Jeffs LP, et al. Towards understanding the de-adoption of low-value clinical practices: a scoping review. BMC Med. 2015;13:255.CrossRefPubMedPubMedCentral
16.
17.
Elshaug AG, Hiller JE, Tunis SR, Moss JR. Challenges in Australian policy processes for disinvestment from existing, ineffective health care practices. Aust New Zealand Health Policy. 2007;4:23.CrossRefPubMedPubMedCentral
18.
Montini T, Graham ID. “Entrenched practices and other biases”: unpacking the historical, economic, professional, and social resistance to de-implementation. Implement Sci. 2015;10:24.CrossRefPubMedPubMedCentral
19.
Polisena J, Clifford T, Elshaug AG, Mitton C, Russell E, Skidmore B. Case studies that illustrate disinvestment and resource allocation decision-making processes in health care: a systematic review. Int J Technol Assess Health Care. 2013;29:174–84.CrossRefPubMed
20.
Roman BR, Asch DA. Faded promises: the challenge of deadopting low-value care. Ann Intern Med. 2014;161:149–50.CrossRefPubMed
21.
22.
Munoz M, Garcia-Erce JA, Villar I, Thomas D. Blood conservation strategies in major orthopaedic surgery: efficacy, safety and European regulations. Vox Sang. 2009;96:1–13.CrossRefPubMed
23.
24.
So-Osman C. Red blood cell transfusion triggers and transfusion alternatives in elective orthopedic hip and knee replacement surgery—a review. Int J Clin Transfus Med. 2015;3:47–54.CrossRef
25.
Spahn DR. Anemia and patient blood management in hip and knee surgery: a systematic review of the literature. Anesthesiology. 2010;113:482–95.CrossRefPubMed
26.
Treloar CJ, Hewitson PJ, Henderson KM, Harris G, Henry DA, McGrath KM. Factors influencing the uptake of technologies to minimize perioperative allogeneic blood transfusion: an interview study of national and institutional stakeholders. Intern Med J. 2001;31:230–6.CrossRefPubMed
27.
Fergusson D, Blair A, Henry D, Hisashige A, Huet C, Koopman-van GA, et al. Technologies to minimize blood transfusion in cardiac and orthopedic surgery. Results of a practice variation survey in nine countries. International study of Peri-operative transfusion (ISPOT) investigators. Int J Technol Assess Health Care. 1999;15:717–28.PubMed
28.
Henry DA, Henderson KM, Fryer JL, Treloar CJ, McGrath KM, Deveridge SF. Use of interventions to minimise perioperative allogeneic blood transfusion in Australia. A survey by the International Study of Perioperative Transfusion (ISPOT) Study Group. Med J Aust. 2000;172:365–9.PubMed
29.
Davies L, Brown TJ, Haynes S, Payne K, Elliott RA, McCollum C. Cost-effectiveness of cell salvage and alternative methods of minimising perioperative allogeneic blood transfusion: a systematic review and economic model. Health Technol Assess. 2006;10:1–114.CrossRef
30.
van Bodegom-Vos L, Voorn VM, So-Osman C, Vliet Vlieland TP, Dahan A, Koopman-van Gemert AW, et al. Cell salvage in hip and knee arthroplasty: a meta-analysis of randomized controlled trials. J Bone Joint Surg Am. 2015;97:1012–21.CrossRefPubMed
31.
Voorn VM, van der Hout A, So-Osman C, Vliet Vlieland TP, Nelissen RG, van den Akker-van Marle ME et al. Erythropoietin to reduce allogeneic red blood cell transfusion in patients undergoing total hip or knee arthroplasty. Vox Sang. 2016;111:219–25.
32.
Alsaleh K, Alotaibi GS, Almodaimegh HS, Aleem AA, Kouroukis CT. The use of preoperative erythropoiesis-stimulating agents (ESAs) in patients who underwent knee or hip arthroplasty: a meta-analysis of randomized clinical trials. J Arthroplasty. 2013;28:1463–72.CrossRefPubMed
33.
So-Osman C, Nelissen RG, Koopman-van Gemert AW, Kluyver E, Poll RG, Onstenk R et al. Patient Blood Management in Elective Total Hip- and Knee-replacement Surgery (Part 1): A Randomized Controlled Trial on Erythropoietin and Blood Salvage as Transfusion Alternatives Using a Restrictive Transfusion Policy in Erythropoietin-eligible Patients. Anesthesiology. 2014;120:839–51.
34.
Bedair H, Yang J, Dwyer MK, McCarthy JC. Preoperative Erythropoietin Alpha Reduces Postoperative Transfusions in THA and TKA but May Not Be Cost-effective. Clin Orthop Relat Res. 2014;473:590–6.
35.
Coyle D, Lee KM, Fergusson DA, Laupacis A. Economic analysis of erythropoietin use in orthopaedic surgery. Transfus Med. 1999;9:21–30.CrossRefPubMed
36.
Struijk-Mulder MC, Horstmann WG, Verheyen CC, Ettema HB. Ten-year follow-up on Dutch orthopaedic blood management (DATA III survey). Arch Orthop Trauma Surg. 2014;134:15–20.CrossRefPubMed
37.
Voorn VM, de Mheen PJ M-v, Wentink MM, So-Osman C, Vliet Vlieland TP, Koopman-van Gemert AW, et al. Frequent use of blood-saving measures in elective orthopaedic surgery: a 2012 Dutch blood management survey. BMC Musculoskelet Disord. 2013;14:230.CrossRefPubMedPubMedCentral
38.
Voorn VM, de Mheen PJ M-v, Wentink MM, Kaptein AA, Koopman-van Gemert AW, So-Osman C, et al. Perceived barriers among physicians for stopping non-cost-effective blood-saving measures in total hip and total knee arthroplasties. Transfusion. 2014;54:2598–607.CrossRefPubMed
39.
Lorencatto F, Stanworth SJ, Gould NJ. Bridging the research to practice gap in transfusion: the need for a multidisciplinary and evidence-based approach. Transfusion. 2014;54:2588–92.CrossRefPubMed
40.
Voorn VM, de Mheen PJ M-v, So-Osman C, Kaptein AA, van der Hout A, van den Akker-van Marle ME, et al. De-implementation of expensive blood saving measures in hip and knee arthroplasties: study protocol for the LISBOA-II cluster randomized trial. Implement Sci. 2014;9:48.CrossRefPubMedPubMedCentral
41.
Michie S, Johnston M, Francis JJ, Hardeman W, Eccles M. From theory to intervention: mapping theoretically derived behavioural determinants to behaviour change techniques. Appl Psychol:An Inter Rev. 2008;57:660–80.CrossRef
42.
Francis JJ, Stockton C, Eccles MP, Johnston M, Cuthbertson BH, Grimshaw JM, et al. Evidence-based selection of theories for designing behaviour change interventions: using methods based on theoretical construct domains to understand clinicians’ blood transfusion behaviour. Br J Health Psychol. 2009;14:625–46.CrossRefPubMed
43.
44.
Andersen LO, Kehlet H. Analgesic efficacy of local infiltration analgesia in hip and knee arthroplasty: a systematic review. Br J Anaesth. 2014;113:360–74.CrossRefPubMed
45.
Thomassen BJ, Touw D, van der Woude P, van der Flier RE, Veld BA I’t. Safety of blood reinfusion after local infiltration analgesia with ropivacaine in total knee arthroplasty. Int J Clin Pharmacol Ther. 2014;52:135–42.CrossRefPubMed
46.
Thomassen BJ, Pool L, Van Der Flier R, Stienstra R, Veld BA I’t. Safety of retransfusing shed blood after local infiltration analgesia in total knee arthroplasty. Acta Orthop Belg. 2012;78:506–11.PubMed
47.
Melvin JS, Stryker LS, Sierra RJ. Tranexamic acid in hip and knee arthroplasty. J Am Acad Orthop Surg. 2015;23:732–40.CrossRefPubMed
48.
Kehlet H, Wilmore DW. Evidence-based surgical care and the evolution of fast-track surgery. Ann Surg. 2008;248:189–98.CrossRefPubMed
49.
Kehlet H, Thienpont E. Fast-track knee arthroplasty—status and future challenges. Knee. 2013;20 Suppl 1:S29–33.CrossRefPubMed
50.
Tinmouth A, Macdougall L, Fergusson D, Amin M, Graham ID, Hebert PC, et al. Reducing the amount of blood transfused: a systematic review of behavioral interventions to change physicians’ transfusion practices. Arch Intern Med. 2005;165:845–52.CrossRefPubMed
51.
Gould NJ, Lorencatto F, Stanworth SJ, Michie S, Prior ME, Glidewell L, et al. Application of theory to enhance audit and feedback interventions to increase the uptake of evidence-based transfusion practice: an intervention development protocol. Implement Sci. 2014;9:92.CrossRefPubMedPubMedCentral
52.
Lorencatto F, Gould NJ, McIntyre SA, During C, Bird J, Walwyn R, et al. A multidimensional approach to assessing intervention fidelity in a process evaluation of audit and feedback interventions to reduce unnecessary blood transfusions: a study protocol. Implement Sci. 2016;11:163.CrossRefPubMedPubMedCentral
53.
So-Osman C, Nelissen RG, Koopman-van Gemert AW, Kluyver E, Poll RG, Onstenk R et al. Patient Blood Management in Elective Total Hip- and Knee-replacement Surgery (Part 2): A Randomized Controlled Trial on Blood Salvage as Transfusion Alternative Using a Restrictive Transfusion Policy in Patients with a Preoperative Hemoglobin above 13 g/dl. Anesthesiology. 2014;120:852–60.
54.
Voorn VM, de Mheen PJ, So-Osman C, Vlieland TP, Gemert AW, Nelissen RG, et al. Designing a strategy to implement cost-effective blood transfusion management in elective hip and knee arthroplasties: a study protocol. Implement Sci. 2012;7:58.CrossRefPubMedPubMedCentral
55.
Thomassen BJ, den Hollander PH, Kaptijn HH, Nelissen RG, Pilot P. Autologous wound drains have no effect on allogeneic blood transfusions in primary total hip and knee replacement: a three-arm randomised trial. Bone Joint J. 2014;96-B:765–71.CrossRefPubMed
Metadata
Title
The effectiveness of a de-implementation strategy to reduce low-value blood management techniques in primary hip and knee arthroplasty: a pragmatic cluster-randomized controlled trial
Authors
Veronique M. A. Voorn
Perla J. Marang-van de Mheen
Anja van der Hout
Stefanie N. Hofstede
Cynthia So-Osman
M. Elske van den Akker-van Marle
Ad A. Kaptein
Theo Stijnen
Ankie W. M. M. Koopman-van Gemert
Albert Dahan
Thea P. M. M. Vliet Vlieland
Rob G. H. H. Nelissen
Leti van Bodegom-Vos
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Implementation Science / Issue 1/2017
Electronic ISSN: 1748-5908
DOI
https://doi.org/10.1186/s13012-017-0601-0

Other articles of this Issue 1/2017

Implementation Science 1/2017 Go to the issue

Research

Advancing theory development: exploring the leadership–climate relationship as a mechanism of the implementation of cultural competence

Research

Process evaluation of a cluster-randomised trial testing a pressure ulcer prevention care bundle: a mixed-methods study

Study protocol

Electronic Laboratory Medicine ordering with evidence-based Order sets in primary care (ELMO study): protocol for a cluster randomised trial

Systematic review

Exploring the factors affecting the implementation of tobacco and substance use interventions within a secondary school setting: a systematic review

Study protocol

Enhancing Mental and Physical Health of Women through Engagement and Retention (EMPOWER): a protocol for a program of research

Study protocol

Design and implementation of electronic health record integrated clinical prediction rules (iCPR): a randomized trial in diverse primary care settings